BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about change in Management
BALAXI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Balaxi Pharmaceuticals has appointed Mr. Aman Purohit as the new Company Secretary and Compliance Officer with effect from March 25, 2026. The appointment was approved by the Board of Directors on the recommendation of the Nomination and Remuneration Committee at a meeting held the same day. Mr. Purohit is an Associate Member of ICSI with 6 years of post-qualification experience in secretarial compliance, having previously worked at Patil Rail Infrastructure and Re Sustainability IWM Solutions. This is a routine KMP-level change and does not involve any board-level or CFO/CEO changes.
This is a routine managerial appointment with no material impact on the company's operations or shareholder value. Retail investors need not take any action; it simply fills a key compliance role required under the Companies Act.